½ÃÀ庸°í¼­
»óǰÄÚµå
1396663

¼¼°èÀÇ ½Å°æ ±â±â ½ÃÀå

Neurology Devices: Global Markets

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BCC Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 102 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ½Å°æ ±â±â ½ÃÀå ±Ô¸ð´Â 2023³â 237¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È 6.0%ÀÇ CAGRÀ» ±â·ÏÇϸç 2028³â¿¡´Â 317¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½Å°æ¿Ü°ú ±â±â ºÎ¹®Àº 2023³â 75¾ï ´Þ·¯¿¡¼­ 5.1%ÀÇ CAGRÀ» ±â·ÏÇϸç 2028³â 96¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ½Å°æÇ÷°ü ±â±â ºÎ¹®Àº 2023³â 59¾ï ´Þ·¯¿¡¼­ 8.7%ÀÇ CAGR·Î 2028³â 89¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ½Å°æ ±â±â ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå Á¤ÀÇ¿Í ¹è°æ, °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø, °¢ ºÎ¹®º°¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, ±â¼ú µ¿Çâ, ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®, ESG Àü°³, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ¿ä¾à°ú ÇÏÀ̶óÀÌÆ®

  • ½ÃÀå Àü¸Á
  • ½ÃÀå ÇÏÀ̶óÀÌÆ®

Á¦3Àå ½ÃÀå ¹è°æ°ú Á¤ÀÇ

  • °³¿ä
  • ½Å°æ ±â±â
  • ½Å°æ¿Ü°ú ±â±â
  • ½Å°æÁ¶Àý ±â±â
  • ½Å°æÇ÷°ü ±â±â
  • ½Å°æÁø´Ü ±â±â
  • Áúȯ ¹è°æ
  • ³úÁ¹Áß
  • ÆÄŲ½¼º´
  • ¾ËÃ÷ÇÏÀ̸Ӻ´
  • °£Áú¡¤¹ßÀÛ
  • °æµ¿¸Æ Áúȯ
  • ³úµ¿¸Æ·ù
  • ÁøÀü
  • ´Ù¹ß¼º °æÈ­Áõ
  • ¿ì¿ïÁõ

Á¦4Àå ½ÃÀå µ¿Çâ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ±âȸ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦5Àå ½ÃÀå ³»¿ª : Á¦Ç° À¯Çüº°

  • °³¿ä
  • ½Å°æ¿Ü°ú ±â±â
  • ½Å°æÁ¶Àý ±â±â
  • ½Å°æÇ÷°ü ±â±â
  • ½Å°æÁø´Ü ±â±â

Á¦6Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • °³¿ä
  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦7Àå ½Å°æ ±â±â ½ÃÀåÀÇ Ãֽе¿Çâ/±â¼ú

  • °³¿ä
  • ½Å°æÇÐÀÇ AI
  • ¿þ¾î·¯ºí ½Å°æ ±â±â
  • ½Å°æ³»°úÀÇ Á¤¹Ð ¹æ»ç¼± Ä¡·á
  • Á¤À§¹æ»ç¼± ¼ö¼ú
  • Á¤À§¹æ»ç¼± Ä¡·á
  • ³ú ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º(BCI)

Á¦8Àå ½Å°æ ±â±â ½ÃÀåÀÇ Áö¼Ó°¡´É¼º : ESG °üÁ¡

  • °³¿ä
  • ESG : ¼­·Ð
  • ȯ°æÀû ¿äÀÎ
  • »çȸÀû ¿äÀÎ
  • °Å¹ö³Í½ºÀû ¿äÀÎ
  • ½Å°æ ±â±â ½ÃÀåÀÇ ESG ÆÛÆ÷¸Õ½º ºÐ¼® : ±â¾÷º°
  • ½Å°æ ±â±â ½ÃÀåÀÇ ESG¿¡ ´ëÇÑ ¼ÒºñÀÚ ÀǽÄ
  • °á·Ð

Á¦9Àå ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®

  • ÀÓ»ó½ÃÇè ½Ã³ª¸®¿À

Á¦10Àå °æÀï »óȲ

  • ¾÷°è ½Ã³ª¸®¿À
  • ±â¾÷ Á¡À¯À²

Á¦11Àå ±â¾÷ °³¿ä

  • ABBOTT
  • AXONICS INC.
  • BOSTON SCIENTIFIC CORP.
  • B. BRAUN SE
  • DANAHER CORP.
  • ELEKTA
  • GE HEALTHCARE
  • INTEGRA LIFESCIENCES
  • JOHNSON & JOHNSON SERVICES INC.
  • KONINKLIJKE PHILIPS N.V.
  • LIVANOVA PLC
  • MEDTRONIC PLC
  • NATUS MEDICAL INC.
  • NEVRO CORP.
  • NIHON KOHDEN CORP.
  • PENUMBRA INC.
  • STRYKER CORP.
  • SIEMENS HEALTHCARE GMBH
  • TERUMO MEDICAL CORP.

Á¦12Àå ºÎ·Ï : µÎ¹®ÀÚ¾î

ksm 23.12.21

Highlights:

The global market for neurology devices is estimated to increase from $23.7 billion in 2023 to reach $31.7 billion by 2028, at a compound annual growth rate (CAGR) of 6.0% from 2023 through 2028.

The global market for neurosurgical devices is estimated to increase from $7.5 billion in 2023 to reach $9.6 billion by 2028, at a compound annual growth rate (CAGR) of 5.1% from 2023 through 2028.

The global market for neurovascular devices is estimated to increase from $5.9 billion in 2023 to reach $8.9 billion by 2028, at a compound annual growth rate (CAGR) of 8.7% from 2023 through 2028.

Report Scope:

This report is a comprehensive study of the global market for neurology devices. It describes the neurology devices market and segments it by product type and region. Based on product type, the market is segmented into neurosurgical devices, neuromodulation devices, neurovascular devices and neurodiagnostic devices. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific and Rest of the World (RoW).

This report examines the factors driving growth in the neurology devices market, and it reviews major players, established companies, and new entrants.

In this report, the neurosurgical devices segment covers neurosurgical instruments, neurosurgery support devices/equipment, such as surgical microscopes, surgery navigation systems, and in the neurodiagnostic segment CT. MRI scanners are also considered as their role is prominent in the diagnosis of brain tumors and for radiosurgery applications. The revenue estimations are done for CT and MRI scans based on the neurology application point of view rather than the sales of the devices in this segment. The report does not cover neuro diagnostic assays, biomarker assays and related IVD instruments. It is purely focused on clinical applications, not research-oriented ones.

Report Includes:

  • 20 data tables and 18 additional tables
  • An overview of the global markets for neurology devices
  • In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
  • Evaluation of the current market size and revenue growth prospects specific to neurology devices, accompanied by a comprehensive market share analysis categorized by product type, and geographical region
  • Discussion on the emerging technologies in neurology devices market and areas of focus to forecast the market into various segments and sub-segments
  • Assessment of the key drivers and constraints that will shape the market for neurology devices and discussion on the upcoming market opportunities
  • Detailed description of the competitive landscape, product mapping, major player's strategic initiatives, R&D activities, and other initiatives
  • Detailed profiles of leading market participants, including Medtronic, Abbott, Terumo, Boston Scientific Corp., Natus Medical Inc., and Siemens Healthineers

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Information Sources
  • Primary Research
  • Secondary Research
  • Geographic Breakdown
  • Segmentation Breakdown

Chapter 2 Summary and Highlights

  • Market Outlook
  • Highlights of the Neurology Devices Market

Chapter 3 Market Background and Definitions

  • Overview
  • Neurology Devices
  • Neurosurgical Devices
  • Neuromodulation Devices
  • Neurovascular Devices
  • Neurodiagnostic Equipment
  • Diseases Background
  • Stroke
  • Parkinson's Disease
  • Alzheimer's Disease
  • Epilepsy and Seizures
  • Carotid Artery Disease
  • Cerebral Aneurysms
  • Tremors
  • Multiple Sclerosis
  • Depression

Chapter 4 Market Trends

  • Market Drivers
  • Aging Population
  • Neurology Disorders and Cancer Cases by Country
  • Penetration of Neurology Devices in Emerging Markets
  • Market Opportunity
  • Market Restraints

Chapter 5 Market Breakdown by Product Type

  • Overview
  • Neurosurgical Devices
  • Neuromodulation Devices
  • Neurovascular Devices
  • Neurodiagnostic Devices

Chapter 6 Market Breakdown by Region

  • Overview
  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 7 Emerging Trends/Technologies in the Neurology Devices Market

  • Overview
  • AI in Neurology
  • Wearable Neurology Devices
  • Precision Radiotherapy in Neurology
  • Stereotactic Radiosurgery
  • Stereotactic Body Radiation Therapy
  • Brain-Computer Interfaces (BCIs)

Chapter 8 Sustainability in Neurology Devices Market: An ESG Perspective

  • Overview
  • Introduction to ESG
  • Environmental Factors
  • Social Factors
  • Governance Factors
  • Neurology Devices Market ESG Performance Analysis by Company
  • Consumer Attitude Towards ESG in the Neurology Devices Market
  • Conclusion

Chapter 9 Pipeline Analysis

  • Clinical Trials Scenario

Chapter 10 Competitive Landscape

  • Industry Scenario
  • Company Shares

Chapter 11 Company Profiles

  • ABBOTT
  • AXONICS INC.
  • BOSTON SCIENTIFIC CORP.
  • B. BRAUN SE
  • DANAHER CORP.
  • ELEKTA
  • GE HEALTHCARE
  • INTEGRA LIFESCIENCES
  • JOHNSON & JOHNSON SERVICES INC.
  • KONINKLIJKE PHILIPS N.V.
  • LIVANOVA PLC
  • MEDTRONIC PLC
  • NATUS MEDICAL INC.
  • NEVRO CORP.
  • NIHON KOHDEN CORP.
  • PENUMBRA INC.
  • STRYKER CORP.
  • SIEMENS HEALTHCARE GMBH
  • TERUMO MEDICAL CORP.

Chapter 12 Appendix: Acronyms

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦